Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Total 10000 results

National Cancer Institute (NCI)

Terminated

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Invasive Thymoma and Thymic Carcinoma | Recurrent Thymoma and Thymic Carcinoma | Stage III Thymoma | Stage IVA Thymoma | Stage IVB Thymoma

United States
Walter Reed National Military Medical Center

Unknown

Study to Reduce Symptoms of Premature Beats With Ranolazine (RSVP)

Premature Ventricular Beats

United States
Children's Hospital of Philadelphia

Completed

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Hyperinsulinism
Merck Sharp & Dohme LLC

Terminated

MK0859 Dose-Ranging Study (0859-003)

Hypercholesterolemia | Mixed Hyperlipemia
Duke University
Bristol-Myers Squibb

Terminated

Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer (TOP0706)

Carcinoma, Non-Small-Cell Lung

United States
JSehouli

Completed

Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer (TRIAS 2009)

Ovarian Cancer

Germany
GlaxoSmithKline

Withdrawn

A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib

Healthy Subjects

United States
Boehringer Ingelheim

Completed

Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors

Neoplasms
University of Medicine and Dentistry of New Jersey
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Expression of Tuberculosis in the Lung

Tuberculosis

Mexico, United States
Brian Lally

Completed

Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain

Brain and Central Nervous System Tumors

United States
ThromboGenics

Completed

Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

Stroke, Acute

Germany, Belgium, Austria
Spanish Oncology Genito-Urinary Group

Completed

Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent (SOGUG-07-01)

Bladder Cancer

Spain
Assistance Publique Hopitaux De Marseille

Terminated

Effectiveness of Permethrin Impregnated Underwear in Preventing Louse Proliferation in Infected Homeless (ERPOUPER)

Body's Louses

France
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation

Completed

Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy

Leukemia

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab

Kidney Cancer

United States
Boehringer Ingelheim

Completed

BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients

Carcinoma, Non-Small-Cell Lung

Italy
Boehringer Ingelheim

Completed

Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers

Healthy
Dana-Farber Cancer Institute

Terminated

Dasatinib in Advanced Squamous Cell Lung Cancer

Squamous Cell Lung Cancer

United States
University Teaching Hospital Hall in Tirol

Completed

Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension (BADDHY)

Hypertension, Pulmonary | Heart Failure, Diastolic

Austria
Singapore General Hospital
Johnson & Johnson

Terminated

Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients

Myelodysplastic Syndrome

Singapore
National Cancer Institute (NCI)

Completed

Belinostat in Treating Patients With Myelodysplastic Syndromes

Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

Heart Diseases | Cardiovascular Diseases | HIV Infections | Insulin Resistance | Hypertriglyceridemia | Hyperlipidemia

United States
AstraZeneca

Completed

Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

LPS Challenge, Neutrophils

United Kingdom
Albany College of Pharmacy and Health Sciences
Albany Medical College

Completed

A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

Obesity

United States
Genzyme, a Sanofi Company

Completed

A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

Acute Myelogenous Leukemia

Japan
Gilead Sciences

Completed

DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension

Hypertension

United States, Spain, Germany, Argentina, Denmark, Brazil, Canada, France, Sweden, United Kingdom, Italy
Universitaire Ziekenhuizen KU Leuven

Completed

Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. (BOMPA)

Heart Septal Defects, Atrial

Belgium
University of Texas Southwestern Medical Center
Novartis Pharmaceuticals

Completed

Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda

Porphyria Cutanea Tarda

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

Endometrial Cancer

United States, Norway, Canada, Australia, Japan
Werner J. Heinz
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis (CASPHYLAX)

Fungal Infection

Germany
Sun Yat-sen University

Unknown

Maintenance Treatment With Capecitabine in Colorectal Cancer Patients

Colorectal Neoplasms | Neoplasms Metastasis

China
SCRI Development Innovations, LLC
Roche Pharma AG; Sanofi-Synthelabo

Completed

Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

Neoplasms, Unknown Primary

United States
Eisai Inc.

Completed

A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndrome

United States
Amgen

Completed

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

Thyroid Cancer
The First Affiliated Hospital with Nanjing Medical...
Academy Military Medical Science, China

Unknown

Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease

Ischemic Heart Disease

China
Vion Pharmaceuticals

Completed

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

Leukemia

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma

Sarcoma

United States
Grupo Oncologico Cooperativo del Sur

Completed

Docetaxel in Treating Patients With Advanced Cancer of the Cervix

Cervical Cancer

Argentina
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
King's College London

Completed

Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

United Kingdom
Centre Jean Perrin

Completed

Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer (PROTAXY)

Metastatic Prostate Cancer

France
National Cancer Institute (NCI)

Completed

6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia

Myelodysplastic Syndromes | Leukemia

United States
Catholic University of the Sacred Heart

Unknown

Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer (MITO15)

BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype

Italy
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer

Breast Cancer | Lung Cancer | Prostate Cancer

United States
University Hospital, Bordeaux

Terminated

A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy (LAPAINBLAD)

Bladder Carcinoma | Cystectomy | Infiltrative Bladder Carcinoma

France
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma

Brain and Central Nervous System Tumors

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma (ITOV04)

Ovarian Cancer | Relapses

France
GlaxoSmithKline

Completed

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Dyslipidaemias

United States, Canada
University of Florida

Terminated

Study of Temozolomide to Treat Newly Diagnosed Brain Metastases

Brain Metastases

United States
European Organisation for Research and Treatment...

Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Cancer

France, Switzerland, Italy, Slovakia, Belgium, Germany, Turkey

Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations